BLING III is out! 🪩🪩🪩 Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis jamanetwork.com/journals/jama/…

We are going to 24 hour pharmacy coverage at the adult ER OU Health. Some night ER pharmacists jobs were approved. oumedicine.wd5.myworkdayjobs.com/en-US/OUHealth… Megan Rech, PharmD, MS Anthony Hawkins

Just published our experience using ceftaroline for invasive Staph infections with CNS or ocular involvement in JAC-AMR, largest case series to date, work led by the amazing Emily Siegrist, check it out! OU Health University of Oklahoma Libraries academic.oup.com/jacamr/article…

Happy to share our latest paper out - A review of recent advances and challenges with herpesviruses in HCT in Clinical Microbiology and Infection, with the great Emily Siegrist, and the best mentor Dr Roy Chemaly! Check it out! #TxID #ChemalyTeam clinicalmicrobiologyandinfection.com/article/S1198-…

Enjoyed working with Joseph Sassine Emily Siegrist and Tali on this thoughtful review of major advances for herpesviruses in transplantation. Long road ahead to conquer these viruses. Clinical Microbiology and Infection

Summary of the Risk Factors, Risk Timelines and Preventive Interventions for Herpesviruses after Allogeneic Hematopoietic Cell Transplantation PET = pre-emptive therapy RZV = recombinant zoster vaccine PALE = post-transplant acute limbic encephalitis doi.org/10.1016/j.cmi.…

ID fellowship applicants, make sure to check our program at OUHSC and OU Health! 2 yr program with opportunities in #TxID, HIV, public health, travel med, IP/ASP and diverse faculty with a wide range of expertise. #IDTwitter medicine.ouhsc.edu/academic-depar…

Ceftaroline may be an option for salvage therapy for severe CNS and ocular infections due to staphylococci when used in combination: doi.org/10.1093/jacamr… Emily Siegrist Joseph Sassine @OUPMedicine Oxford Journals #JACAMRNews

Excited to see Rebecca Mayes PGY-2 research in print. In a study of ICU patients, repeat positive FUBC with GNR bacteremia was 28.4%, higher than seen with other studies. Lack of source control was a risk factor for repeat positive FUBC. academic.oup.com/jacamr/article…

Check out poster 1557, work led by the great Emily Siegrist, cefazolin/ceftriaxone predict cefpodoxime but not cefuroxime susceptiblility in Enterobacterales uUTI Bryan White Nayle Ibragimova IDWeek SIDP OU Health #IDWeek2024

Another poster by the OU ID pharmacy group, Nayle Ibragimova’s evaluation of the DRIP score for MDR community onset pneumonia at our institution Emily Siegrist Bryan White OU College of Pharmacy Residency Programs SIDP OU Health IDWeek #IDWeek2024

Presented at #IDWeek2024: An innovative remote therapeutic monitoring device, with an integrated care platform, allowed us to reduce odds of infection-related readmission by 68% up to 90 days after discharge in patients on OPAT at OU Health! ou.edu/news/articles/…

Our large database analysis @TriNetX of viral and fungal infections after CAR T cell therapy is out now at Clinical Microbiology and Infection! With Emily Siegrist Andrés Henao, MD, PhD Rita Wilson Dib Jose Andres Henao Cordero MD Daniel Chastain Chia-Yu Chiu et al. OU College of Medicine #TxID #lymsm #mmsm 🧵 clinicalmicrobiologyandinfection.com/article/S1198-…

We have an ID fellowship opening at the University of Oklahoma OU College of Medicine, starting July 2025. Two-year program, with great exposure to HIV, immunocompromised ID and surgical infections, and above all, great people to train with! DM me for details!

INTEGRIS Health is looking to hire an ID/ASP pharmacy specialist at our flagship campus in OKC. We’re a level II trauma center with transplant and ECMO. Feel free to reach out with any questions. #TwitteRx #IDTwitter ertr.fa.us2.oraclecloud.com/hcmUI/Candidat…

Our new paper on vancomycin AUC dosing in obesity is out. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry, PharmD, BCPS . Emily Siegrist was on it as well. Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟

And part 2 is out now: How to prevent travel-related infections in the transplant recipient, check it out! Emily Siegrist Rita Wilson Dib Jose Andres Henao Cordero MD Therapeutic Advances in Infectious Disease Andrés Henao, MD, PhD journals.sagepub.com/doi/full/10.11…

Out now in JAC-AMR, our real world analysis of BCID fungal panel for diagnosis of fungemia, led by the great Emily Siegrist - Sensitivity of 94%, lower than anticipated Bryan White Rita Wilson Dib OU College of Medicine OU Health academic.oup.com/jacamr/article…

🚨New article alert! We used the GenMark panel for rapid yeast ID in blood cultures. We got faster ID, but didn’t de-escalate therapy based on it. Full story + data here 👉 academic.oup.com/jacamr/article… Rita Wilson Dib Joseph Sassine SIDP

ID fellowship applicants, make sure to check out our program OU College of Medicine: 2 year clinical program - 3 tracks (TxID, hosp epi, trop med) - Path for crit care fellowship - 12 credit certificates in year 2 medicine.ouhsc.edu/academic-depar…